"St. David's South Austin Medical Center provides convenient, comprehensive healthcare and leading-edge services"

During the past decade, St. David's South Austin medical Center conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 4 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 2 clinical trials were completed. i.e. 11.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. David's South Austin medical Center" #1 sponsor was "Allogene Therapeutics" with 4 trials, followed by "Harvard Pilgrim Health Care" with 3 trials sponsored, "SCRI Development Innovations, LLC" with 3 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored and "Accumetrics, Inc." with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. David's South Austin medical Center" #1 collaborator was "Centers for Disease Control and Prevention" with 3 trials as a collaborator, "University of California, Irvine" with 3 trials as a collaborator, "University of Massachusetts, Amherst" with 3 trials as a collaborator, "Brigham and Women's Hospital" with 2 trials as a collaborator and "Hospital Corporation of America Healthcare (HCA)" with 2 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "St. David's South Austin medical Center" are "Multiple Myeloma" (2 trials), "Myelodysplastic Syndromes" (2 trials), "Relapsed/Refractory Large B Cell Lymphoma" (2 trials), "Relapsed/Refractory Multiple Myeloma" (2 trials) and "AML, Adult" (1 trials). Many other conditions were trialed in "St. David's South Austin medical Center" in a lesser frequency.

Most popular intervention types in "St. David's South Austin medical Center" are "Drug" (22 trials), "Biological" (7 trials), "Genetic" (4 trials), "Other" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (7 trials), "Fludarabine" (7 trials), "ALLO-647" (4 trials), "Placebo" (3 trials) and "INSPIRE CPOE Smart Prompt" (2 trials). Other intervention names were less common.

The vast majority of trials in "St. David's South Austin medical Center" are 26 trials for "All" genders.

Currently, there are NaN active trials in "St. David's South Austin medical Center". undefined are not yet recruiting, 10 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in St. David's South Austin medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in St. David's South Austin medical Center, 7 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".

St. David's South Austin medical Center has several departments that took part in Clinical trials: "Heart Hospital of Austin" - 24 trials, "Austin Cancer Centers-Saint David's" - 3 trials